SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001558370-19-011368
Filing Date
2019-12-05
Accepted
2019-12-05 17:03:50
Documents
8
Effectiveness Date
2019-12-05

Document Format Files

Seq Description Document Type Size
1 S-3ASR s-3asr.htm S-3ASR 807539
3 EX-4.7 ex-4d7.htm EX-4.7 600760
4 EX-5.1 ex-5d1.htm EX-5.1 50559
5 EX-5.2 ex-5d2.htm EX-5.2 11695
6 EX-23.1 ex-23d1.htm EX-23.1 8050
7 GRAPHIC s-3asrg001.jpg GRAPHIC 18292
8 GRAPHIC s-3asrg002.jpg GRAPHIC 141422
9 GRAPHIC s-3asrg003.jpg GRAPHIC 75472
  Complete submission text file 0001558370-19-011368.txt   1803782
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-235372 | Film No.: 191270937
SIC: 2834 Pharmaceutical Preparations